- About Our Work
- Research Prize Projects
- Human Co-operation at UCL
- The Alzheimer Enigma in an Ageing World
- Solving the Mystery of the Biology of Ageing
- The Search For Drugs That Slow Ageing - Are We There Yet? and Why Not?
- UCL’s Festival of Ageing
- UCL's Festival of Ageing Research Prize Workshop
- Workshop Requirements
- Choreographing architectural gestures in urban spaces & sPins
- Two events commissioned by one of the cross-disciplinary research projects awarded a prize at the Behaviour Change Research Prize Workshop
- Tackling Age Inequalities: a research agenda
- What are the important questions for research into ageing? A public engagement workshop for people aged 70 and over.
- How Universities Can Help Create a Wiser World
- Research Expertise
- Getting Involved
- Contact us
- Small Grants
- Ageing Initiative
Click below to share this pageTweet
Published: Aug 26, 2014 9:00:00 AM
Published: Aug 11, 2014 10:00:00 AM
Published: Aug 8, 2014 12:00:00 PM
- UCL researchers: Why contribute to The Conversation?
- Activities supported by the 2014-15 GCHW Small Grants Scheme
- Do We Need an Academic Revolution?
- Winning project from our £10,000 Ageing Research Prize Workshop
- Grand Challenges Student Fund: up to £750 available for student led projects – More
The Alzheimer Enigma in an Ageing World
Thursday 24 October (6pm-7.30pm) followed by a drinks reception
A lecture by Professor Margaret Lock , Marjorie Bronfman Professor in Social Studies of Medicine, Emerita, Dept. of Social Studies of Medicine, McGill University
Alzheimer’s disease is increasingly described today as an epidemic, with estimates of 115 million cases worldwide by 2050. Less visible are the ongoing epistemological arguments in the medical world about the observed entanglements of AD type dementia with “normal” aging, and the repeated efforts to delineate what exactly constitutes this elusive yet devastating condition. In early 2011 official statements appeared in relevant medical journals about a so-called paradigm shift involving a move towards a preventative approach to AD in which the detection of biomarkers indicative of prodromal Alzheimer’s disease is central. In this talk I will discuss the significance of risk predictions associated with such biomarkers, and the irresolvable uncertainties such information raises for involved individuals and families.
Welcome: Professor Andrew Steptoe, Director, Institute of Epidemiology and Health Care, UCL
Introduction and chair: Dr Sahra Gibbon, UCL Anthropology
Page last modified on 13 nov 13 09:09